Asian Patients with Chronic Genotype 2 HCV Infection Achieve 98% Sustained Virologic Response Following 12 Week administration of Sofosbuvir in Combination with Ribavirin: Integrated analysis of Phase 3 Multicenter Studies

臺大醫學院;臺大醫學院-臨床醫學研究所;Omata, MasaoMasaoOmataLim, Young-SukYoung-SukLimChuang, Wan-LongWan-LongChuangKao, Jia-HorngJia-HorngKaoGao, BingBingGaoDe-Oertel, ShampaShampaDe-OertelYang, Jenny C.Jenny C.YangMo, HongmeiHongmeiMoBrainard, Diana M.Diana M.BrainardKnox, Steven J.Steven J.KnoxMcHutchison, John G.John G.McHutchisonMizokami, MasashiMasashiMizokamiHan, Kwang-HyubKwang-HyubHan2017-06-222018-07-062017-06-222018-07-062015http://ntur.lib.ntu.edu.tw//handle/246246/279876Asian Patients with Chronic Genotype 2 HCV Infection Achieve 98% Sustained Virologic Response Following 12 Week administration of Sofosbuvir in Combination with Ribavirin: Integrated analysis of Phase 3 Multicenter Studies